Results for tag: "Ursodeoxycholic Acid"

Ursodeoxycholic Acid (UDCA) is a bile acid used in the treatment of gastrointestinal diseases. It is used to treat primary biliary cirrhosis, a chronic liver disease, and to dissolve gallstones. UDCA is also used to treat other conditions such as primary sclerosing cholangitis, biliary atresia, and cholestatic liver diseases. It is available in oral and intravenous forms. UDCA is a naturally occurring bile acid found in the small intestine and is used to reduce the amount of cholesterol in bile. It is also used to reduce the risk of gallstone formation and to reduce the symptoms of gallbladder disease. The UDCA market is a part of the larger gastrointestinal drugs market. It is a growing market, driven by the increasing prevalence of gastrointestinal diseases and the increasing demand for effective treatments. The market is expected to grow due to the increasing awareness of the benefits of UDCA and the increasing availability of generic versions of the drug. Some of the major companies in the UDCA market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more